Who Paid My Doc
Vyxeos
Drug Hematology/Oncology
NDC 68727-745-01
General payments
$1,192,682
Research payments
$71,818,769
Through program year 2021, $1,192,682 in general payments and $71,818,769 in research payments were reported against Vyxeos (Hematology/Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $582,503 | 2,740 |
| 2021 | Research | $37,111,818 | 538 |
| 2020 | General | $610,179 | 1,247 |
| 2020 | Research | $34,706,951 | 516 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.
The top 5 of 63 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 46 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
3,987 general · 1,054 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.